1. Tissue Engineered Ovary
   Monica M. Laronda, 2020, Organ Tissue Engineering CrossRef
2. Müllerian inhibiting substance inhibits an ovarian cancer cell line via β-catenin interacting protein deregulation of the Wnt signal pathway
   Sang Ho Park et al, 2017, International Journal of Oncology CrossRef
3. Engineering a bioprosthetic ovary for fertility and hormone restoration
   Monica M. Laronda, 2020, Theriogenology CrossRef
4. M�llerian inhibiting substance/anti‑M�llerian hormone type II receptor protein and mRNA expression in the healthy and cancerous endometria
   Su Kim et al, 2018, Oncology Letters CrossRef
5. Anti-Müllerian Hormone Expression in Endometrial Cancer Tissue
   Marek Gowkielewicz et al, 2019, International Journal of Molecular Sciences CrossRef
6. The humanized anti-human AMHRII mAb 3C23K exerts an anti-tumor activity against human ovarian cancer through tumor-associated macrophages
   Houcine Bougherara et al, 2017, Oncotarget CrossRef
7. The expression of Müllerian inhibiting substance/anti-Müllerian hormone type II receptor in myoma and adenomyosis
   Shin Young Kim et al, 2018, Obstetrics & Gynecology Science CrossRef
8. Expression of Müllerian-Inhibiting Substance/Anti-Müllerian Hormone Type II Receptor in the Human Theca Cells
   Keun Young Cheon et al, 2018, The Journal of Clinical Endocrinology & Metabolism CrossRef
9. Tissue-Engineered Ovary
   Monica M. Laronda, 2021, Organ Tissue Engineering CrossRef
10. Assessment of Anti-Mullerian Hormone and Anti-Mullerian Hormone Type II Receptor Variants in Women with Repeated Implantation Failures
    Yun-xing Fu et al, 2021, Reproductive Sciences CrossRef